Compare RLAY & FIGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RLAY | FIGS |
|---|---|---|
| Founded | 2015 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2020 | 2021 |
| Metric | RLAY | FIGS |
|---|---|---|
| Price | $7.82 | $9.93 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 5 |
| Target Price | ★ $16.00 | $8.60 |
| AVG Volume (30 Days) | 2.3M | ★ 2.8M |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 91.65 |
| EPS | N/A | ★ 0.11 |
| Revenue | $8,355,000.00 | ★ $581,034,000.00 |
| Revenue This Year | $27.30 | $4.73 |
| Revenue Next Year | $7.43 | $3.67 |
| P/E Ratio | ★ N/A | $92.94 |
| Revenue Growth | N/A | ★ 5.90 |
| 52 Week Low | $1.78 | $3.57 |
| 52 Week High | $8.36 | $10.24 |
| Indicator | RLAY | FIGS |
|---|---|---|
| Relative Strength Index (RSI) | 64.31 | 68.65 |
| Support Level | $6.28 | $9.46 |
| Resistance Level | $8.36 | $9.83 |
| Average True Range (ATR) | 0.50 | 0.48 |
| MACD | 0.14 | 0.03 |
| Stochastic Oscillator | 76.56 | 81.67 |
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
FIGS Inc is a healthcare apparel company. The Company designs and sells scrubwear and non-scrubwear, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear and other apparel. The Company generates maximum revenue from United States. Sales are generated through the Company's digital platforms.